CD47 and neoplasm: Whereas both macrophages and DC benefit from CD47 blockade in terms of phagocytic uptake of tumor cells, Xu et al recently found that CD47 blockade also selectively enhances innate immune sensing of tumor mitochondrial DNA (mtDNA) in DC by activating NOX2 and limiting the phagosomal acidification that otherwise degrades this DNA within macrophages.